首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Detection and Identification of Mycobacterium spp. in Clinical Specimens by Combining the Roche Cobas Amplicor Mycobacterium tuberculosis Assay with Mycobacterium Genus Detection and Nucleic Acid Sequencing
【2h】

Detection and Identification of Mycobacterium spp. in Clinical Specimens by Combining the Roche Cobas Amplicor Mycobacterium tuberculosis Assay with Mycobacterium Genus Detection and Nucleic Acid Sequencing

机译:分枝杆菌属的检测和鉴定。罗氏Cobas Amplicor结核分枝杆菌测定与分枝杆菌属检测和核酸测序相结合的临床标本

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have recently developed a PCR assay for detection of Mycobacterium spp. at the genus level based on the Cobas Amplicor platform. The sensitivities for smear-positive and smear-negative specimens were found to be 100% and 47.9%, respectively. The specificity was 97.7%, the positive predictive value 84.6%, and the negative predictive value 93.1%. In a follow-up study, we have systematically evaluated the Mycobacterium genus assay in parallel with the Cobas Amplicor Mycobacterium tuberculosis assay on 2,169 clinical specimens, including respiratory and nonrespiratory specimens. Based on the genus assay, nontuberculous mycobacteria were readily detected and identified to the species level by PCR-mediated sequencing. In addition, our data point to a limited specificity of the Cobas Amplicor M. tuberculosis assay.
机译:我们最近开发了一种用于检测分枝杆菌属的PCR检测方法。基于Cobas Amplicor平台的属级。涂片阳性和涂片阴性标本的敏感性分别为100%和47.9%。特异性为97.7%,阳性预测值为84.6%,阴性预测值为93.1%。在一项后续研究中,我们对2169份临床标本(包括呼吸道和非呼吸道标本)与Cobas Amplicor结核分枝杆菌测定同时进行了系统评价,评估了分枝杆菌属测定。基于属分析,很容易检测到非结核分枝杆菌,并通过PCR介导的测序将其鉴定到物种水平。此外,我们的数据表明Cobas Amplicor结核分枝杆菌测定的特异性有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号